Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with limited infrastructure.
Scientists at the Broad Institute of MIT and Harvard and collaborators in the U.S, Nigeria, and Sierra Leone have now validated such tests for Ebola and Lassa – two of the deadliest and most transmissible human viruses – in settings with limited infrastructure. The work appeared in Nature Communications.
Tags:
Source: Broad Institute
Credit: Photo: C. S. Goldsmith, Transmission electron microscopic image of three Lassa virus particles, Centers for Disease Control and Prevention.
